Dsuvia
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.dsuvia.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Dsuvia
DSUVIA is a non-invasive investigational product candidate consisting of 30 mcg sufentanil tablets delivered sublingually by a healthcare professional using a disposable, pre-filled, single-dose applicator (SDA). Sufentanil is a synthetic opioid analgesic with a high therapeutic index and no known active metabolites.Explore more
Popular SearchesDsuviaAcelRx Pharmaceuticals IncSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dsuvia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Dsuvia recently announced quarterly report
Click to see if Dsuvia had a recent Job posting/layoffs
Product Launch: Get notified when Dsuvia launches new products
Check out if Dsuvia is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Dsuvia
Dsuvia, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Dsuvia has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Dsuvia has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Dsuvia as Masked Content
Find more new buyers
Compare Similar Companies to Dsuvia
Compare insights from companies similar to Dsuvia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Dsuvia
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Dsuvia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Dsuvia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Dsuvia.
Dsuvia Tech Stack
A closer look at the technologies used by Dsuvia
Dsuvia News & Media
AcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora Pharmaceuticals
Agreement with Alora Pharmaceuticals provides AcelRx with 15% royalties on commercial sales, 75% royalties on Department of Defense (DoD) sales, up to $116.5 million in potential sales-based milestone payments, and a strong commercial partner experienced with commercialization in hospital...AcelRx Pharmaceuticals Announces ANESTHESIOLOGY® 2022 Annual Meeting Presentation on DSUVIA® for Battlefield Analgesia by the Uniformed Services University of the Health Sciences
Presentation concludes that future battlefield medicine efforts should focus on newer analgesics like DSUVIA® across military settings and establish protocols for their implementation in the trauma setting HAYWARD, Calif., Oct. 25, 2022 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc....AcelRx Pharmaceuticals Provides Update on Reduced FDA REMS Requirements Related to DSUVIA®
HAYWARD, Calif., May 19, 2022 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported that the U.S. Food...AcelRx Pharmaceuticals Announces Publication of an Article Highlighting the Utility of the Sufentanil Sublingual Tablet in Pain Medicine Procedures
HAYWARD, Calif., Jan. 27, 2022 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the publication of an article...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dsuvia
Sign Up For FreeTo access detailed company insights
DSUVIA is a non-invasive investigational product candidate consisting of 30 mcg sufentanil tablets delivered sublingually by a healthcare professional using a disposable, pre-filled, single-dose applicator (SDA). Sufentanil is a synthetic opioid analgesic with a high therapeutic index and no known active metabolites.... Read More
